Viatris (VTRS) Total Liabilities (2018 - 2026)
Viatris (VTRS) recorded quarterly Total Liabilities of $22.2 billion in Q1 2026, down 1.36% quarter-over-quarter from $22.5 billion in Q4 2025, and down 2.84% on a YoY basis from $22.8 billion in Q1 2025.
Viatris (VTRS) Total Liabilities (2018 - 2026) Analysis & Trends
Viatris' Total Liabilities history runs 9 years deep, the most recent figure standing at $22.2 billion for Q1 2026.
- In Q1 2026, Total Liabilities fell 2.84% year-over-year to $22.2 billion; the TTM figure through Mar 2026 stood at $22.2 billion (down 2.84% YoY), while the FY2025 annual figure was $22.5 billion, down 1.68% from the prior year.
- Total Liabilities was $22.2 billion for Q1 2026 at Viatris, down from $22.5 billion in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $33.0 billion in Q1 2022 to a low of $22.2 billion in Q1 2026.
- Historically, Total Liabilities has averaged $26.4 billion across 5 years, with a median of $27.2 billion in 2023.
- Biggest YoY gain for Total Liabilities was 1.68% in 2025; the steepest drop was 16.48% in 2025.
- A 5-year view of Total Liabilities shows it stood at $28.9 billion in 2022, then slipped by 5.98% to $27.2 billion in 2023, then dropped by 15.99% to $22.9 billion in 2024, then decreased by 1.68% to $22.5 billion in 2025, then dropped by 1.36% to $22.2 billion in 2026.
- The last three Total Liabilities figures came in at $22.2 billion (Q1 2026), $22.5 billion (Q4 2025), and $22.7 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 31.81 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 11.92 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 813.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 148.77 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.50 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.72 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.51 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.13 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.82 Bn |
| 10 | Viatris | - | - | 1.16 Bn | 22.18 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.18 Bn |
| Dec 31, 2025 | 22.48 Bn |
| Sep 30, 2025 | 22.70 Bn |
| Jun 30, 2025 | 22.84 Bn |
| Mar 31, 2025 | 22.82 Bn |
| Dec 31, 2024 | 22.87 Bn |
| Sep 30, 2024 | 24.96 Bn |
| Jun 30, 2024 | 25.81 Bn |
| Mar 31, 2024 | 27.33 Bn |
| Dec 31, 2023 | 27.22 Bn |
| Sep 30, 2023 | 27.88 Bn |
| Jun 30, 2023 | 27.85 Bn |
| Mar 31, 2023 | 28.36 Bn |
| Dec 31, 2022 | 28.95 Bn |
| Sep 30, 2022 | 29.48 Bn |
| Jun 30, 2022 | 31.32 Bn |
| Mar 31, 2022 | 33.02 Bn |
| Dec 31, 2021 | 34.35 Bn |
| Sep 30, 2021 | 34.93 Bn |
| Jun 30, 2021 | 36.78 Bn |